| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.21 | 0.001 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |